November 5, 2025 · Form 4 insider transaction
Chambers Rebecca sold 7,000 shares of Veracyte, Inc. at $41.00 per share, a transaction worth $287.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024.